Search research articles
Contact Us
Filters
Showing results (611-620 of 621) with videos related to
Page
of 63
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
January 15, 2002
Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant
Catherine S Choong, Peter J Fuller, Simon Chu, et al.
Angiogenesis
|
July 18, 2018
PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation
R Gianni-Barrera, A Butschkau, A Uccelli, et al.
Journal of the National Cancer Institute
|
December 24, 2013
Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study
Samuel Shapiro, Tobie J deVilliers, Amos Pines, et al.
Voprosy Onkologii
|
October 26, 1999
[Inhibin and ovarian cancer]
H G Burger, A Baillie, A E Drummond, et al.
Nucleic Acids Research
|
March 21, 1998
Genome structure and gene content in protist mitochondrial DNAs
M W Gray, B F Lang, R Cedergren, et al.
Journal of Reproductive Immunology
|
October 24, 1998
Inhibin and ovarian cancer
H G Burger, A Baillie, A E Drummond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial
Mace L Rothenberg, Amit M Oza, Robert H Bigelow, et al.
Climacteric : the Journal of the International Menopause Society
|
April 1, 2005
Guidelines for hormone treatment of women in the menopausal transition and beyond
F Naftolin, H P G Schneider, D W Sturdee, et al.
Lijecnicki Vjesnik
|
October 1, 2005
[Guidelines for hormone treatment of women in the menopausal transition and beyond: position statement by the Executive Committee of the International Menopause Society]
F Naftolin, H P G Schneider, I D W Sturdee, et al.
Journal of Andrology
|
June 27, 2003
Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone
Pierre-Marc G Bouloux, Eberhard Nieschlag, Henry G Burger, et al.
Page
of 63
Search research articles
Search
Showing results (611-620 of 621) with videos related to
Sort By:
Page
of 63
The Journal of Clinical Endocrinology and Metabolism
|
January 15, 2002
Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant
Catherine S Choong, Peter J Fuller, Simon Chu, et al.
Angiogenesis
|
July 18, 2018
PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation
R Gianni-Barrera, A Butschkau, A Uccelli, et al.
Journal of the National Cancer Institute
|
December 24, 2013
Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study
Samuel Shapiro, Tobie J deVilliers, Amos Pines, et al.
Voprosy Onkologii
|
October 26, 1999
[Inhibin and ovarian cancer]
H G Burger, A Baillie, A E Drummond, et al.
Nucleic Acids Research
|
March 21, 1998
Genome structure and gene content in protist mitochondrial DNAs
M W Gray, B F Lang, R Cedergren, et al.
Journal of Reproductive Immunology
|
October 24, 1998
Inhibin and ovarian cancer
H G Burger, A Baillie, A E Drummond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial
Mace L Rothenberg, Amit M Oza, Robert H Bigelow, et al.
Climacteric : the Journal of the International Menopause Society
|
April 1, 2005
Guidelines for hormone treatment of women in the menopausal transition and beyond
F Naftolin, H P G Schneider, D W Sturdee, et al.
Lijecnicki Vjesnik
|
October 1, 2005
[Guidelines for hormone treatment of women in the menopausal transition and beyond: position statement by the Executive Committee of the International Menopause Society]
F Naftolin, H P G Schneider, I D W Sturdee, et al.
Journal of Andrology
|
June 27, 2003
Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone
Pierre-Marc G Bouloux, Eberhard Nieschlag, Henry G Burger, et al.
Page
of 63